Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects
Articolo
Data di Pubblicazione:
2013
Abstract:
Aim: Recent studies suggest that the incretin concept is not restricted to glucose ingestion but relevant also after non-glucose macronutrient
administration. We therefore hypothesized that raising incretin hormones reduces circulating glucose after both glucose and non-glucose
macronutrient ingestion in healthy subjects.
Methods: Twelve healthy subjects received the dipeptidyl peptidase-4 inhibitor sitagliptin (100 mg) or placebo before ingestion of glucose,
fat (olive oil) or protein mix in equicaloric amounts (8 kcal/kg) plus paracetamol (1.5 g). The 120-min areas under curve (AUC) of intact
glucagon-like peptide-1 (GLP-1), glucose, insulin, C-peptide, glucagon and paracetamol, and model-derived insulin secretion rate (ISR), insulin
sensitivity, insulin clearance and glucose absorption were measured.
Results: The increased plasma intact GLP-1 levels after each macronutrient was augmented by sitagliptin. This was associated with a robust
lowering of glucose: glucose excursion after oral glucose was diminished, and glucose fell below baseline after oral fat and protein. In spite
of lower glucose, AUCC-peptide and ISR did not differ significantly between sitagliptin and placebo after any macronutrient. AUCglucagon, insulin
sensitivity and insulin clearance were also not different between sitagliptin and placebo. Glucose absorption after oral glucose was reduced by
sitagliptin, whereas AUCparacetamol was not statistically different between sitagliptin and placebo.
Conclusions: Physiological elevation of intact GLP-1 levels after ingestion of glucose and non-glucose macronutrients is robustly glucoselowering
in healthy subjects. Hence, the incretin concept is not restricted to glucose ingestion in normal physiology. The glucose-lowering
action of sitagliptin at these low glucose levels in healthy subjects may have complex mechanisms, involving both islet-dependent and
islet-independent mechanisms.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
DPP-4 inhibition; humans; insulin secretion; macronutrients; sitagliptin
Elenco autori:
Tura, Andrea; Pacini, Giovanni; Mari, Andrea
Link alla scheda completa:
Pubblicato in: